Madrigal Pharmaceuticals Inc. logo

Madrigal Pharmaceuticals Inc.

MDGL | NASDAQ
Chart Builder DCF Calculator
$521.96
-$9.56 (-1.80%)
At close: Sep 21, 2026, 4:00 PM ET
$521.96
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-288.28M -465.89M -373.63M -295.35M -241.85M -202.24M
Depreciation & Amortization
4.72M 696K 527K 467K 405K 471K
Stock-Based Compensation
98.13M 79.88M 49.74M 31.63M 26.87M 20.73M
Other Working Capital
103.86M -13K -7.49M 35.15M 10.29M 23.64M
Other Non-Cash Items
4.38M 2.09M 2.41M 797K 7.32M 21.83M
Deferred Income Tax
n/a n/a n/a n/a -7.32M -21.83M
Change in Working Capital
-8.5M -72.35M -3.28M 37.6M 30.65M 23.48M
Operating Cash Flow
-189.55M -455.57M -324.23M -224.86M -183.92M -157.56M
Capital Expenditures
-467K -1.46M -1.48M -217K -209K -334K
Cash Acquisitions
n/a n/a n/a -3K 787K 1.92M
Purchase of Investments
-1.05B -1.13B -834.44M -143.48M -394.12M -329.34M
Sales Maturities Of Investments
1.09B 839.19M 333.4M 350.38M 389.27M 489.46M
Other Investing Acitivies
-8.97M 19.09M n/a 3K -787K -1.92M
Investing Cash Flow
32.32M -274.39M -502.52M 206.69M -5.06M 159.78M
Debt Repayment
217.93M n/a 65M 50M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 337.58M 269.93M 8.07M 1.03M 667K
Financial Cash Flow
255.98M 735.06M 595.12M 313.45M 171.24M 5.09M
Net Cash Flow
98.76M 5.1M -231.63M 295.28M -17.74M 7.31M
Free Cash Flow
-190.02M -457.03M -325.71M -225.07M -184.13M -157.9M
Adj. Free Cash Flow
-288.15M -536.91M -375.44M -256.7M -211M -178.63M
Maintenance CapEx
n/a n/a -527K -217K -209K -334K
Growth CapEx
-467K -1.46M -952K n/a n/a n/a
Owner Earnings
-189.55M -455.57M -324.76M -225.07M -184.13M -157.9M

© 2026 bestshares.com. All rights reserved.